Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Statistics in Medicine

• Publication date

  1987-04-01

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1002/SIM.4780060308PMID 3616282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Why do we need some large, simple randomized trials?

  1984cited by this paper
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

  1976cited by this paper

• Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials.

  2026cites this paper
• Evolution of Evidence-Based Medicine in Stroke

  2021cites this paper
• Making trials part of good clinical care: lessons from the RECOVERY trial

  2021cites this paper
• Meta-Analyses in Plastic Surgery: Can We Trust Their Results?

  2019cites this paper
• Diagnostic accuracy of fetal MRI to detect cleft palate: a meta-analysis

  2019cites this paper
• Fondaparinux Sodium Compared With Low‐Molecular‐Weight Heparins for Perioperative Surgical Thromboprophylaxis: A Systematic Review and Meta‐analysis

  2019cites this paper
• Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: systematic review, network meta-analysis and cost analysis.

  2017cites this paper
• Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

  2017cites this paper
• Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism.

  2017cites this paper
• Interpretation of the evidence for the efficacy and safety of statin therapy.

  2016cites this paper
• Randomised trials in context: practical problems and social aspects of evidence-based medicine and policy

  2015cites this paper
• Using a matrix-analytical approach to synthesizing evidence solved incompatibility problem in the hierarchy of evidence.

  2015cites this paper
• Lithium as an adjunct to radioactive iodine for the treatment of hyperthyroidism: a systematic review and meta-analysis.

  2014cites this paper
• Modernizing Evidence Synthesis for Evidence-Based Medicine

  2014cites this paper
• Covariate Imbalance, Adjustment for †

  2014cites this paper
• Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism.

  2014cites this paper
• Meta-Analysis in Clinical Risk Assessment†

  2014cites this paper
• Successful Scientific Writing by Janice R. Matthews

  2014cites this paper
• Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism.

  2014cites this paper
• Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism.

  2013cites this paper
• Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.

  2013cites this paper
• The role of primary and secondary care in the management of pulmonary embolism : A shifting paradigm? Developments in diagnosis and treatment

  2013cites this paper
• Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.

  2013cites this paper
• Impediments to Clinical Research in the United States

  2012cites this paper
• Tissue Doppler imaging for diagnosis of coronary artery disease: a systematic review and meta-analysis

  2012cites this paper
• Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

  2012cites this paper
• meta- analytic review Efficacy of drug treatment in obsessive-compulsive disorder. A

  2011cites this paper
• A Bayesian subgroup analysis with a zero‐enriched Polya Urn scheme

  2011cites this paper
• Issues in Data Analysis

  2010cites this paper
• Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.

  2010cites this paper
• Large-scale randomized evidence: Trials and meta-analyses of trials

  2010cites this paper
• Osteoinductive bone graft substitutes for lumbar fusion: a systematic review.

  2009cites this paper
• Randomized trials published in some Chinese journals: how many are randomized?

  2009cites this paper
• Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis.

  2008cites this paper
• Outcome Studies Comparing Regional and General Anesthesia

  2007cites this paper
• Evidence based medicine methods (part 2): extension into the clinical area

  2007cites this paper
• Meta-analyses in Cancer Clinical Trials: Principles and Pitfalls

  2006cites this paper
• Os dez mandamentos do ensaio clínico randomizado - princípios para avaliação crítica da literatura médica

  2006cites this paper
• Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism.

  2006cites this paper
• The Likelihood as Statistical Evidence in Multiple Comparisons in Clinical Trials: No Free Lunch

  2006cites this paper
• Interpretation of subgroup results in clinical trial publications: insights from a survey of medical specialists in Ontario, Canada.

  2006cites this paper
• Meta-analyses in Cancer Clinical Trials: Principles and Pitfalls

  2006cites this paper
• Statistical Analysis of Cost-Effectiveness Data

  2006cites this paper
• Evaluating the evidence from clinical trials in chronic hepatitis C

  2006cites this paper
• Misuse of Baseline Comparison Tests and Subgroup Analyses in Surgical Trials

  2006cites this paper
• Cost-effectiveness analyses alongside randomised clinical trials

  2006cites this paper
• A critical appraisal and defence of the Oxfordshire low back pain trial

  2005cites this paper
• High-dosage vitamin E supplementation and all-cause mortality.

  2005cites this paper
• High-Dosage Vitamin E Supplementation and All-Cause Mortality

  2005cites this paper
• High-dosage vitamin E supplementation and all-cause mortality.

  2005cites this paper
• How to ensure your paper is rejected by the statistical reviewer

  2005cites this paper
• Covariate Imbalance, Adjustment for

  2005cites this paper
• Multiplicity in Clinical Trials

  2005cites this paper
• Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism

  2005cites this paper
• Systematic Reviews of Nonrandomized Clinical Studies in the Orthopaedic Literature

  2004cites this paper
• We could all learn from the Italian cardiologists.

  2004cites this paper
• An evidence based approach to optimizing anticoagulant strategies

  2004cites this paper
• Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.

  2004cites this paper
• Correlation between thrombus regression and recurrent venous thromboembolism. Examining venographic and clinical effects of low‐molecular‐weight heparins: a meta‐analysis

  2004cites this paper
• BRITISH CARDIOLOGY British Heart Foundation surveys ( 1987 and 1989 ) of United Kingdom treatment policies for acute myocardial infarction

  2004cites this paper
• Risk factors for bleeding during treatment with anti-thrombotics

  2004cites this paper
• Naloxone for shock.

  2003cites this paper
• Low-Molecular-Weight Heparin and Cancer Survival: Review of the Literature and Pooled Analysis of 1,726 Patients Treated for at Least Three Months

  2003cites this paper
• Once versus twice daily LMWH for the initial treatment of venous thromboembolism.

  2003cites this paper
• Meta-analysis in medicine.

  2003cites this paper
• Low‐molecular‐weight heparin for the long‐term treatment of symptomatic venous thromboembolism: meta‐analysis of the randomized comparisons with oral anticoagulants

  2003cites this paper
• How to Write and Illustrate a Scientific Paper

  2003cites this paper
• Simplified meta-analysis of clinical trials in resuscitation.

  2003cites this paper
• The use of Bayesian confidence propagation neural network in pharmacovigilance

  2003influential citation
• Using the expected survival to explain differences between the results of randomized trials: a case in advanced ovarian cancer.

  2003cites this paper
• Naltrexone maintenance treatment for opioid dependence.

  2003cites this paper
• Funding, disease area, and internal validity of hepatobiliary randomized clinical trials

  2002cites this paper
• Chemotherapy in gastric cancer: a review and updated meta-analysis

  2002cites this paper
• Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies.

  2002cites this paper
• Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

  2002cites this paper
• Chemotherapy in gastric cancer: a review and updated meta-analysis.

  2002cites this paper
• Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial.

  2002cites this paper
• The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.

  2002cites this paper
• Once versus twice daily LMWH for the initial treatment of venous thromboembolism.

  2002cites this paper
• Contribution of meta-analyses to the evaluation of treatments for advanced colorectal cancer

  2002cites this paper
• Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials.

  2001cites this paper
• Meta-Analyses in Orthopaedic Surgery: A Systematic Review of Their Methodologies

  2001cites this paper
• The Role of Meta-analyses in Clinical Research: Uses and Limitations

  2001cites this paper
• The effect of antihypertensive treatment on cardiovascular events--a meta-analysis of four clinical trials in China.

  2001cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• [Reflections on some methodological errors in the evaluation of drugs. Ten years experience at the National Marketing Authorization Commission].

  2001cites this paper
• The Effects of Vitamin K-antagonists on Survival of Patients with Malignancy: A Systematic Analysis

  2001cites this paper
• Why evidence-based medicine?

  2001cites this paper
• Effectiveness in Conservation Practice: Pointers from Medicine and Public Health

  2001cites this paper
• Réflexions sur quelques erreurs méthodologiques communes dans l’évaluation des médicaments. Dix ans d’expérience à la Commission d’autorisation de mise sur le marché

  2001cites this paper
• Adjuvant Therapy for Patients with Node Negative Breast Cancer

  2000cites this paper
• Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.

  2000cites this paper
• Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Sarcoma Meta-analysis Collaboration (SMAC).

  2000cites this paper
• Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials.

  2000cites this paper
• Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults.

  2000cites this paper
• Do the low molecular weight heparins improve efficacy and safety of the treatment of deep venous thrombosis? A meta-analysis.

  2000cites this paper
• Low-Molecular-Weight Heparins: Are They Interchangeable?

  2000cites this paper
• Control of error in randomized clinical trials.

  2000cites this paper
• Meta-analysis: methods, strengths, and weaknesses.

  2000cites this paper
• Evaluation of clinical studies of the efficacy of therapeutic apheresis

  2000cites this paper